We found that G9a was upregulated in most multiple myeloma cell lines (MMCLs) and patient samples and that knockdown of G9a inhibited proliferation, colony formation of MMCLs in vitro as well as the tumorigenesis of MMCLs in vivo. This evidence concerns the gene EHMT2 and plasma cell myeloma.